logo
Trump casts psychiatric and weight-loss drugs as threats to children

Trump casts psychiatric and weight-loss drugs as threats to children

Yahoo18-02-2025
President Donald Trump has instructed his administration to scrutinize the 'threat' to children posed by antidepressants, stimulants and other common psychiatric drugs, targeting medication taken by millions in his latest challenge to long-standing medical practices.
The directive came in an executive order Thursday that established a 'Make America Healthy Again' commission led by Health and Human Services Secretary Robert F. Kennedy Jr., who has criticized the use of those drugs and issued false claims about them.
Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post.
The order said the commission should prepare a 'Make Our Children Healthy Again' assessment within 100 days that examines 'the prevalence of and threat posed by the prescription of selective serotonin reuptake inhibitors, antipsychotics, mood stabilizers, stimulants, and weight-loss drugs.' The directive comes as children and teens endure a mental health crisis exacerbated by the coronavirus pandemic.
Kennedy also has made childhood nutrition and healthful food a signature issue. He has been critical of the boom in weight loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro.
The medication review joins a slew of Trump administration policies upending the government's approach to health, many of which are embroiled in legal challenges. They include attempts to remove vaccine information from health agency websites, to ban gender transition care for children and to cut billions in biomedical research funding.
Kush Desai, a White House spokesman, said the order follows concerns about doctors overprescribing the drugs and harming Americans of all ages. The president called for a review of prescription practices and use of the drugs to determine whether the government should offer new guidance on the medication.
'The Trump administration will continue to review current best practices in patient care and scientific research to implement needed reforms,' Desai said in an email.
Marketa M. Wills, chief executive officer of the American Psychiatric Association, said psychiatric drugs can be very effective and generally are given to children carefully after front-line treatments such as talk therapy.
'In many cases, they can give children their lives back,' Wills said. 'It's a long, involved process before kids get started on medication, and it's done judiciously.'
As with nearly every medication, medical professionals have debated the protocols for providing children psychiatric and weight-loss drugs, as well as ways to balance the risks and benefits.
In 2021, 8 percent of children between the ages of 5 and 17 received medication for their mental health, according to the Centers for Disease Control and Prevention. An analysis by MedPage Today found that in September 2024 there were more than 125,000 prescriptions written for GLP-1 weight loss drugs by pediatric and adolescent medicine specialists, up from nearly 60,000 in October 2022.
Jonathan Zhang, an assistant professor at Duke University's Sanford School of Public Policy, said many drugs used to treat mental health conditions in the United States are being used off-label in children. Additional research would be beneficial, he said, but medication usage should be considered in the context of the limited availability of therapists and alternative treatments.
'There is a growing mental health crisis among youth, so if there is overutilization of medication, in part it is also an access and provider shortage problem,' Zhang said.
- - -
Kennedy's controversial mental health comments
Some mainstream public health experts have doubted that Kennedy, a lawyer who founded an anti-vaccine organization, is qualified to craft sound policy given his lack of medical training and long history of promoting conspiracy theories and sloppy research.
In interviews and public statements over the years, Kennedy has compared antidepressants and weight-loss drugs to controlled substances. He has said antidepressants are harder to quit than heroin, a claim contradicted by research and experts. He told Fox News in October that pharmaceutical companies are counting on selling weight-loss medication to Americans because patients are 'stupid' and 'addicted to drugs.'
Kennedy has speculated that psychiatric drugs lead to mass shootings at schools, claims that are not grounded in credible research.
In an April interview with YouTuber George Janko, Kennedy said the National Institutes of Health should override medical privacy rules to determine whether mass shooters used SSRIs.
During his short-lived presidential campaign, Kennedy proposed creating wellness farms where young people could 'get off' SSRIs and Adderall, a stimulant widely used to treat attention-deficit/hyperactivity disorder. Those comments were first reported by Mother Jones.
A Washington Post review of Kennedy's public appearances found he also promoted these centers as particularly beneficial for Black youth.
'Every Black kid is now just standard put on Adderall, on SSRIs, benzos, which are known to induce violence, and those kids are going to have a chance to go somewhere and get re-parented, to live in a community where there'll be no cellphones, no screens. You'll actually have to talk to people,' Kennedy said in a June episode of the 19Keys online show.
- - -
Antidepressants
The rate of antidepressant prescriptions for adolescents has jumped sharply in recent years, rising 43 percent between 2016 and 2022, according to a paper published last year in the journal of the American Academy of Pediatrics.
Wills, of the American Psychiatric Association, said antidepressants are not meant to be a front-line treatment for children. They are used when other treatment such as talk therapy is not working.
Awais Aftab, a psychiatrist in Cleveland, said there are legitimate questions surrounding proper use of psychiatric drugs in children because of side effects, limited data on long-term use and evidence that SSRIs are less effective in young people.
'Psychiatric medications are being used because there is a genuine clinical need,' Aftab said in an email. 'The response should not be to restrict access to medication by thinking their use is unnecessary, but rather, the goal should be to increase access to high-quality clinical care that goes beyond reliance on medications.'
- - -
Stimulants
The scrutiny of stimulants such as Adderall comes as parents and children have confronted shortages.
The use of stimulants by adults has spiked in recent years but has been largely stagnant or declining in children and teenagers, according to an analysis of commercial insurance claims by the Centers for Disease Control and Prevention. In 2021, about 10 percent of boys and 5 percent of girls ages 10 to 14 received a stimulant, the review showed.
'I'm worried about the proliferation of stimulants and mind altering substances,' Kennedy said during a 2023 C-SPAN appearance. 'I don't think it's a good thing for people.'
Max Wiznitzer, a professor of pediatrics and neurology at Case Western University and specialist in ADHD, said research has shown stimulants are highly effective and side effects such as decreased appetite rare.
He said that stimulants are best used as a bridge to help children develop good behavioral habits. But he questioned whether the Trump administration is acting in good faith in evaluating their use.
'That is not an open-minded approach to the medication by using the word threat,' Wiznitzer said.
- - -
Weight-loss drugs
The Food and Drug Administration approved Ozempic for use in children in 2023. The same year, the American Academy of Pediatrics updated its guidance to recommend use of the drugs for children ages 12 and up with obesity and, in some cases, for children as young as 8.
Mark Fendrick, professor of health management and policy at the University of Michigan, said it was 'very surprising' to see weight-loss drugs grouped in with other medications that Trump said should be assessed as potential threats.
He said there have been numerous recent peer-reviewed studies - including one published in January in Nature Medicine that have shown the drugs to be safe and effective for a wide range of indications.
Fendrick said he supports Kennedy's emphasis on healthy eating as a way to combat the nation's obesity epidemic. However, he said that being able to treat children with GLP-1 medications will pay off in future health gains.
'Many people only have a short window for success, and these efforts that are outlined like reducing ultra-processed foods can take multiple decades to achieve,' Fendrick said.
Related Content
'Green lairds' are buying vast estates in Scotland for carbon credits
'Just freaking incredible': Alabama was suddenly the epicenter of basketball
Opossum eats whole Costco chocolate cake, fans have big feelings: 'Me too girl'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Rollins extends sugary drinks ban to six more states — including Louisiana
Rollins extends sugary drinks ban to six more states — including Louisiana

American Press

time21 minutes ago

  • American Press

Rollins extends sugary drinks ban to six more states — including Louisiana

U.S. Secretary of Agriculture Brooke Rollins approved six waivers to exclude sodas and energy drinks from federal nutrition programs on Monday. Rollins signed waivers exempting soda and energy drinks from being included in the Supplemental Nutrition Assistance Programs in Colorado, Florida, Louisiana, Oklahoma, Texas and West Virginia. The six states join Arkansas, Idaho, Iowa, Indiana, Utah and Nebraska in restricting sodas and energy drinks from SNAP. 'Since my confirmation, our department has encouraged states to think differently and creatively about how to solve the many health issues facing Americans,' Rollins said. 'One way is by not allowing taxpayer-funded benefits to be used to purchase unhealthy items like soda, candy and other junk food.' Critics of the new push to ban soda and energy drinks under SNAP say it unfairly targets lower-income families, limits consumer choice and won't result in better health outcomes. Colorado Gov. Jared Polis is the first Democrat governor to request a waiver of sugary drinks from the states SNAP program. 'This is not red or blue, Republican or Democrat. We are discussing and working with every state. So (I am) really excited to continue to work with Gov. Polis,' Rollins said. Secretary of Health and Human Services Robert F. Kennedy Jr., Food and Drug Administration Commissioner Marty Makary, Iowa Gov. Kim Reynolds and West Virginia Gov. Patrick Morrisey joined Rollins for the announcement. Morrisey praised his state's inclusion as part of the SNAP waiver program. He said the lack of access to healthy foods in West Virginia contributes to the prevalence of chronic disease in residents. 'I'm happy now that West Virginia taxpayers are not going to be subsidizing soda and these sugary drinks, things that have no nutritional value and are directly linked to obesity, diabetes, and a lot of other terrible health care outcomes,' Morrisey said. HHS Secretary Kennedy agreed with Morrisey. He said the inclusion of soda and energy drinks in SNAP increases the cost to medicaid and medicare programs due to increased chronic disease. 'U.S. taxpayers should not be paying to feed kids foods – the poorest kids in our country – with foods that are the gift of diabetes. And my agency ends up through Medicaid and Medicare paying for those injuries,' Kennedy said. Kennedy also gave an update on the dietary guidelines for Americans that he is working alongside Rollins to complete. He said the guidelines will be complete in late September, 'three months ahead of schedule.' 'They will drive changes in the school lunch program, in prison lunches and military food, and they will begin to change America almost immediately,' Kennedy said. Not everyone agrees. 'Make no mistake, this waiver won't make an ounce of difference on health,' the trade organization American Beverage said when a waiver was being discussed in Ohio. 'Obesity has skyrocketed in the last two decades while beverage calories per serving have dropped by 42% – thanks to our industry's efforts to empower Americans with more choice and information. In fact, 60% of beverages Americans buy today have zero sugar due to our innovation.' The U.S. government spent $112.8 billion on SNAP in 2023, covering 100% of the cost of food benefits and 50% of states' administrative costs.

25 states file legal brief defending Trump ban on youth sex change procedures
25 states file legal brief defending Trump ban on youth sex change procedures

American Press

time21 minutes ago

  • American Press

25 states file legal brief defending Trump ban on youth sex change procedures

On Monday, Louisiana Attorney General Liz Murrill joined 24 other Republican attorneys general in backing President Donald Trump's executive order aimed at halting federal funding for sex change procedures on minors, marking the state's latest push in a broader legal fight over transgender care. Three days earlier, Massachusetts filed a brief joined by 19 states challenging the same executive order. The states argue the order is unconstitutional, discriminatory, and violates the Spending Clause by tying federal health funds to ideological conditions. The Massachusetts-led brief contends that the order jeopardizes care for transgender youth, strips states of medical decision-making authority, and undermines long-standing Medicaid protections. The suit seeks a declaratory judgment and permanent injunction against implementation. The attorneys general defending the Trump order, led by Alabama's Steve Marshall, filed amicus briefs in the 4th and 9th U.S. Circuit Courts of Appeals, supporting Trump's order and urging the courts to overturn preliminary injunctions issued earlier this year in lawsuits out of Washington and Maryland. The Alabama-led briefs argue that continuing to fund such procedures violates both medical ethics and constitutional principles. 'Even though President Trump is in office, common sense and constitutional principles are under constant assault by radical leftist groups like the ACLU,' said Alabama Attorney General Steve Marshall, who is leading the coalition. Marshall accused the ACLU of pushing courts to 'force taxpayers to fund sex-change procedures on children.' Murrill, who has been an outspoken critic of so-called 'gender-affirming' care for minors, did not release a separate public statement, but her participation in the brief underscores Louisiana's alignment with a growing number of Republican-led states that seek to limit access to such treatments. In recent years, Louisiana's Legislature has passed bans on puberty blockers and hormone treatments for minors. According to the coalition's legal filings, the brief draws on findings from Alabama's discovery in a now-dismissed challenge to its own ban on 'gender-affirming' care, where Marshall's office claimed to uncover a coordinated effort to remove age restrictions from national medical guidelines — a move he described as politically motivated rather than science-based. The Alabama-led team argues that federal funding for 'gender-affirming' care is based on 'discredited standards' and that such medical interventions for minors have irreversible consequences. 'The evidence says otherwise,' Marshall said. 'These harmful interventions have lasting consequences for vulnerable children.' The Alabama-led brief was filed in both the 9th Circuit and 4th Circuit federal courts of appeal. Louisiana was joined by attorneys general from Alaska, Arkansas, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Mississippi, Missouri, Nebraska, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, and Wyoming in addition to Louisiana. The filings are part of a broader conservative legal strategy seeking to bolster state laws banning so-called 'gender-affirming' care while reinforcing Trump-era federal policy that frames such care as medically unnecessary and ideologically driven.

Will feds weigh in on religious vax carveouts?
Will feds weigh in on religious vax carveouts?

Politico

time22 minutes ago

  • Politico

Will feds weigh in on religious vax carveouts?

Driving the Day RELIGIOUS VAX EXEMPTIONS — It's back-to-school season, which means parents are shuttling their kids to pediatricians for annual checkups — and advocates for and against states' exemptions to vaccine mandates for school entry are gearing up for a fight, Lauren reports. Vaccine skeptics have sought to make their case to the Trump administration's Religious Liberty Commission — created by executive order in May — for executive action to bolster religious carve-outs. But they face pushback from public health experts who warn that more exemptions could threaten public health, setting up another front in the vaccine wars. Four states — California, Connecticut, Maine and New York — don't offer religious exemptions to school vaccine requirements, and Massachusetts lawmakers are considering banning them. West Virginia provides exemptions after GOP Gov. Patrick Morrisey signed an executive order earlier this year invoking the state's religious freedom law. Some religious liberty groups have called on the federal government — which has no say in state vaccine mandates — to use federal education funding as leverage to expand religious opt-outs from school immunization requirements, pointing to a Clinton-era religious protection statute. Precedential web: Some vaccine law experts question how far the executive branch could go to nudge those outlier states toward accepting religious exemptions. The Supreme Court curtailed the Religious Freedom Restoration Act's application to the states in 1997, and administrative conditions on federal funding can't run afoul of Congress' directions. But proponents say those lawyers ignore more recent opinions that work in exemption advocates' favor, pointing to a Covid-19-era decision lifting in-home gathering restrictions on religious grounds and, more recently, the court's ruling in favor of parents who want to opt their children out of LGBTQ+-themed lessons in public schools. Shifting winds: The number of kindergarteners entering school with at least one vaccine exemption continues to tick up, with the CDC reporting last week that 3.6 percent had one in the 2024-2025 school year, compared with 2.2 percent a decade ago. Days before the updated data was released, the American Academy of Pediatrics reaffirmed its opposition to religious exemptions, arguing they should be abolished to protect public health. 'In practice, nonmedical exceptions based on religious belief can substantially limit the public health value of vaccine requirements for school attendance,' the group said in a statement. 'There is no practicable way for schools or other involved community partners to distinguish fairly among religious or other nonmedical claims.' What's next: The Religious Liberty Commission will hold a hearing next month on public education issues, giving exemption proponents another opening to make their case. It's unclear where the White House stands on the concept — a spokesperson didn't comment — but the first Trump administration's HHS pursued avenues to grant health care workers expanded 'conscience' protections and to allow imports of certain vaccines due to some patients' religious beliefs. IT'S TUESDAY. WELCOME BACK TO PRESCRIPTION PULSE. Your host is wondering whether concerns about a common allergy medicine's risks might catch the FDA's attention. Send tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). Eye on the FDA NEW TOP LAWYER — FDA Commissioner Marty Makary named a longtime government attorney on Monday to be the agency's chief counsel, months after his first pick was torpedoed by Sen. Josh Hawley (R-Mo.). Sean Keveney, who most recently served as HHS's acting general counsel, served as a career civil servant at DOJ's civil rights division before becoming deputy general counsel at HHS in 2019, according to the department and his LinkedIn profile. His predecessor in the position, Hilary Perkins, was also a career DOJ lawyer whose appointment drew Hawley's ire before Makary's confirmation because of her record defending the Biden administration's abortion pill policies. While Perkins also defended the Trump FDA's mifepristone positions, that wasn't enough to overcome his opposition, and she ultimately stepped down days into the job. MDUFA KICKOFF — The FDA's medical device user fee program is not set to expire until Sept. 30, 2027, but the process to renew it has already begun. Despite HHS Secretary Robert F. Kennedy Jr.'s vocal distaste for the user fee programs, the Trump administration has made it clear they are committed to the monthslong process that will likely result in their renewal for another five years. Industry and FDA leaders — including FDA Commissioner Marty Makary and Center for Devices and Radiological Health Director Michelle Tarver — met Monday to discuss the potential sixth iteration of the medical device user fee program. 'While user fees support timeliness and predictability by providing FDA with additional resources, user fees are not a guarantee of approval,' AdvaMed's senior executive vice president, Janet Trunzo, said according to prepared remarks. 'They never have been, and they never should be.' In Congress SENATE PASSES FDA FUNDING — Before leaving town for the August recess, the Senate passed a bill to fund the FDA for fiscal 2026 as part of a minibus package by an 87-9 vote. The legislation, which funds the agency at $7 billion, is made up of $3.6 billion in taxpayer funds and $3.4 billion in user fee revenues. But it is unclear whether lawmakers will have to turn to a continuing resolution before government funding runs out at the end of September. The House Appropriations Committee previously advanced an FDA bill that funded the agency at a lower level. Research Corner BOOST FOR WOMEN'S HEALTH — The Gates Foundation said Monday it would spend $2.5 billion through 2030 to speed global women's research into maternal, menstrual, gynecological and sexual health. Pharma Moves Erika Sward is now chief advocacy officer at UsAgainstAlzheimer's. She previously was assistant vice president of national advocacy at the American Lung Association. Document Drawer FDA Commissioner Marty Makary met with Rep. John Joyce (R-Pa.) for an introductory meeting on July 24. He also met with People for the Ethical Treatment of Animals to discuss nonanimal testing approaches on July 21, according to newly posted public calendar disclosures. He also met with the leadership team of the Government Accountability Office on July 16 to discuss 'items of mutual interest.' WHAT WE'RE READING Top FDA cancer medicine regulator Richard Pazdur played a critical role in the rejection of Replimune Group's skin cancer therapy, STAT's Adam Feuerstein reports. Longevity companies are eyeing Montana as a potential hub for 'biohacking' treatments thanks to state laws embracing patients' 'right-to-try' experimental drugs, The Wall Street Journal's Alex Janin writes.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store